3/18
09:15 am
cyth
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/18
09:05 am
cyth
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Low
Report
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
3/14
09:40 am
cyth
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's Disease [Yahoo! Finance]
3/14
09:34 am
cyth
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
Low
Report
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
2/12
01:18 am
cyth
Cyclodextrin Market Size Worth $579.6 Million by 2032 | CAGR: 5.7%: AMR [Yahoo! Finance]
Low
Report
Cyclodextrin Market Size Worth $579.6 Million by 2032 | CAGR: 5.7%: AMR [Yahoo! Finance]
1/29
09:29 am
cyth
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office [Yahoo! Finance]
Medium
Report
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office [Yahoo! Finance]
1/29
09:15 am
cyth
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
Low
Report
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office